BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 29440233)

  • 1. Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma.
    Arnes L; Liu Z; Wang J; Maurer C; Sagalovskiy I; Sanchez-Martin M; Bommakanti N; Garofalo DC; Balderes DA; Sussel L; Olive KP; Rabadan R
    Gut; 2019 Mar; 68(3):499-511. PubMed ID: 29440233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC.
    Li J; Liu D; Hua R; Zhang J; Liu W; Huo Y; Cheng Y; Hong J; Sun Y
    Pancreatology; 2014; 14(5):385-90. PubMed ID: 25200694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
    Lin W; Noel P; Borazanci EH; Lee J; Amini A; Han IW; Heo JS; Jameson GS; Fraser C; Steinbach M; Woo Y; Fong Y; Cridebring D; Von Hoff DD; Park JO; Han H
    Genome Med; 2020 Sep; 12(1):80. PubMed ID: 32988401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma.
    Wu Y; Wei J; Ming Y; Chen Z; Yu J; Mao R; Chen H; Zhou G; Fan Y
    J Cell Biochem; 2018 Sep; 119(9):7696-7706. PubMed ID: 29923223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes.
    Maurer C; Holmstrom SR; He J; Laise P; Su T; Ahmed A; Hibshoosh H; Chabot JA; Oberstein PE; Sepulveda AR; Genkinger JM; Zhang J; Iuga AC; Bansal M; Califano A; Olive KP
    Gut; 2019 Jun; 68(6):1034-1043. PubMed ID: 30658994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer.
    Tahira AC; Kubrusly MS; Faria MF; Dazzani B; Fonseca RS; Maracaja-Coutinho V; Verjovski-Almeida S; Machado MC; Reis EM
    Mol Cancer; 2011 Nov; 10():141. PubMed ID: 22078386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma.
    Fu XL; Liu DJ; Yan TT; Yang JY; Yang MW; Li J; Huo YM; Liu W; Zhang JF; Hong J; Hua R; Chen HY; Sun YW
    Sci Rep; 2016 Sep; 6():33535. PubMed ID: 27628540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma.
    Yang H; Zhang W; Ding J; Hu J; Sun Y; Peng W; Chu Y; Xie L; Mei Z; Shao Z; Xiao Y
    Front Immunol; 2022; 13():970588. PubMed ID: 36148233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annotation and functional characterization of long noncoding RNAs deregulated in pancreatic adenocarcinoma.
    da Paixão VF; Sosa OJ; da Silva Pellegrina DV; Dazzani B; Corrêa TB; Risério Bertoldi E; da Cruz E Alves-de-Moraes LB; de Oliveira Pessoa D; de Paiva Oliveira V; Alberto Chiong Zevallos R; Russo LC; Forti FL; Eduardo Ferreira J; Carioca Freitas H; Jukemura J; Machado MCC; Dirlei Begnami M; Setubal JC; Bassères DS; Moraes Reis E
    Cell Oncol (Dordr); 2022 Jun; 45(3):479-504. PubMed ID: 35567709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma.
    Hao S; Yao L; Huang J; He H; Yang F; Di Y; Jin C; Fu D
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617748429. PubMed ID: 29343207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray expression profile analysis of long non-coding RNAs in pancreatic ductal adenocarcinoma.
    Zhou Y; Gong B; Jiang ZL; Zhong S; Liu XC; Dong K; Wu HS; Yang HJ; Zhu SK
    Int J Oncol; 2016 Feb; 48(2):670-80. PubMed ID: 26676849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma.
    Cui H; Zhang Y; Zhang Q; Chen W; Zhao H; Liang J
    Cancer Med; 2017 Dec; 6(12):2932-2941. PubMed ID: 29047230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of distinct long noncoding RNA transcriptional fingerprints in pancreatic ductal adenocarcinoma.
    Yu X; Lin Y; Sui W; Zou Y; Lv Z
    Cancer Med; 2017 Mar; 6(3):673-680. PubMed ID: 28220683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma.
    Ding YC; Yu W; Ma C; Wang Q; Huang CS; Huang T
    Int J Clin Exp Pathol; 2014; 7(11):8065-70. PubMed ID: 25550852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility.
    Corradi C; Gentiluomo M; Gajdán L; Cavestro GM; Kreivenaite E; Di Franco G; Sperti C; Giaccherini M; Petrone MC; Tavano F; Gioffreda D; Morelli L; Soucek P; Andriulli A; Izbicki JR; Napoli N; Małecka-Panas E; Hegyi P; Neoptolemos JP; Landi S; Vashist Y; Pasquali C; Lu Y; Cervena K; Theodoropoulos GE; Moz S; Capurso G; Strobel O; Carrara S; Hackert T; Hlavac V; Archibugi L; Oliverius M; Vanella G; Vodicka P; Arcidiacono PG; Pezzilli R; Milanetto AC; Lawlor RT; Ivanauskas A; Szentesi A; Kupcinskas J; Testoni SGG; Lovecek M; Nentwich M; Gazouli M; Luchini C; Zuppardo RA; Darvasi E; Brenner H; Gheorghe C; Jamroziak K; Canzian F; Campa D
    Int J Cancer; 2021 Jun; 148(11):2779-2788. PubMed ID: 33534179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long non-coding RNA DKFZp434J0226 regulates the alternative splicing process through phosphorylation of SF3B6 in PDAC.
    Li J; Tong H; Li D; Jiang Q; Zhang Y; Tang W; Jin D; Chen S; Qin X; Zhang S; Xue R
    Mol Med; 2021 Aug; 27(1):95. PubMed ID: 34470609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
    Ramnarine VR; Alshalalfa M; Mo F; Nabavi N; Erho N; Takhar M; Shukin R; Brahmbhatt S; Gawronski A; Kobelev M; Nouri M; Lin D; Tsai H; Lotan TL; Karnes RJ; Rubin MA; Zoubeidi A; Gleave ME; Sahinalp C; Wyatt AW; Volik SV; Beltran H; Davicioni E; Wang Y; Collins CC
    Gigascience; 2018 Jun; 7(6):. PubMed ID: 29757368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma.
    Birnbaum DJ; Begg SKS; Finetti P; Vanderburg C; Kulkarni AS; Neyaz A; Hank T; Tai E; Deshpande V; Bertucci F; Birnbaum D; Lillemoe KD; Warshaw AL; Mino-Kenudson M; Fernandez-Del Castillo C; Ting DT; Liss AS
    Clin Cancer Res; 2021 Apr; 27(8):2314-2325. PubMed ID: 33547202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
    Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J
    J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.